Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2009
11/26/2009WO2008145281A8 Formulations containing triazinones and iron
11/26/2009WO2008124907A8 Resveratrol-containing composition for modulating bone formation
11/26/2009WO2008122858A8 Crystalline forms of 6- [2- (methylcarbamoyl) phenylsulfanyl] -3-e- [2- (pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
11/26/2009WO2008095597A3 Transdermal therapeutic system for administering water-soluble active ingredients
11/26/2009WO2007084221A9 Methods and apparatus for identifying subject matter in view data
11/26/2009US20090292238 Paeoniflorin preparations and uses thereof for fat reduction
11/26/2009US20090292028 Menthol-containing formulation
11/26/2009US20090292027 Compositions for the treatment of signs of aging
11/26/2009US20090292026 Treatment of CNS Disorders With trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1-Napthalenamine
11/26/2009US20090292025 Novel crystalline forms of armodafinil and preparation thereof
11/26/2009US20090292024 Substituted propanamide derivative and pharmaceutical composition containing the same
11/26/2009US20090292023 treating acute post-osteotomy pain with diclofenac potassium
11/26/2009US20090292022 Method of Treating Post-Surgical Acute Pain
11/26/2009US20090292021 Anticonvulsive pharmaceutical compositions
11/26/2009US20090292020 Use of calcium salt of polyenoic acid in medical and cosmetic field
11/26/2009US20090292019 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
11/26/2009US20090292018 Dicarbonic Acid Derivatives, Metastasis Inhibitors and Agents Increasing Chemotherapeutic Activity of Anti-Tumor Preparations, Method for Enhancing the Cytostatic Efficiency and Metastasis Process Inhibiting Method
11/26/2009US20090292017 Therapeutic compositions
11/26/2009US20090292016 Stable Pharmaceutical Compositions Containing Pravastatin
11/26/2009US20090292015 Stable high vitamin c content polyol-in-oil emulsified system and its preparation
11/26/2009US20090292014 Benzofuran derivatives useful for treating hyper-proliferative disorders
11/26/2009US20090292013 In-Situ Forming Implant for Animals
11/26/2009US20090292012 Therapeutic Agent
11/26/2009US20090292011 Pharmaceutical composition for the treatment or prevention of diseases involving obesity, diabetes, metabolic syndrome, neuro-degenerative diseases and mitochondria dysfunction diseases
11/26/2009US20090292010 Sweetener compositions and methods of making them
11/26/2009US20090292009 Modulation of stat 6 expression
11/26/2009US20090292008 Compositions and Methods for Treatment of Prostate and Other Cancers
11/26/2009US20090292007 Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation
11/26/2009US20090292005 L- alpha -dioleoyl phosphatidyl{14-N-(1-deoxylactito-1-yl)amino-3,6,9,12-tetraoxa}tetra decanol; 2-O-{2-N-(1-deoxylactito-1-yl)aminoethyl} carbamoyl-1,3-O-dioleoyl glycerol; galactose, a suitable spacer and a certain lipid, a drug carrier; efficiently transferred into the liver
11/26/2009US20090292004 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
11/26/2009US20090292003 Cell penetrating peptides for intracellular delivery of molecules
11/26/2009US20090292002 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
11/26/2009US20090292001 Tricyclic derivatives as potent and selective histone deacetylase inhibitors
11/26/2009US20090292000 Pyrrolidine derivatives as prostaglandin modulators
11/26/2009US20090291999 Agent Exhibiting a Neurotropic, Neuromodulator, Cerebrovascular and Anti-Stroke Activity
11/26/2009US20090291998 Eponemycin and epoxomicin analogs and uses thereof
11/26/2009US20090291997 Carvedilol dihydrogen phosphate monohydrate
11/26/2009US20090291996 Caspofungin free of caspofungin Co
11/26/2009US20090291995 bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; enhanced solubility and bioavailability compared with free acid; agonist of TPO receptor, enhances platelet production; thrombocytopenia
11/26/2009US20090291993 Difluorophenol Derivatives and Their Use
11/26/2009US20090291992 Androgen receptor-ablative agents
11/26/2009US20090291991 Isoindoline compounds and methods of their use
11/26/2009US20090291990 Oxadiazolyl-phenoxyalkylisoxazoles, compositions thereof and methods for their use as anti-picornaviral agents
11/26/2009US20090291989 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
11/26/2009US20090291988 Reversible Inhibitors of Monoamine Oxidase A and B
11/26/2009US20090291987 Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl) carbamic acid 2-(s)-hydroxymutilin 14-ester
11/26/2009US20090291986 Composition and method of treating facial skin defect
11/26/2009US20090291985 Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
11/26/2009US20090291984 Substituted pyrazoles, compositions containing these, method of production and use
11/26/2009US20090291983 3-Oxoisoindoline-1-Carboxamide Derivatives as Analgesic Agents
11/26/2009US20090291982 New Substituted Oxindole Derivative 352
11/26/2009US20090291981 5-Lipoxygenase-Activating Protein Inhibitor
11/26/2009US20090291980 Triglyceride-lowering agent and hyperinsulinism-ameliorating agent
11/26/2009US20090291979 Tricyclic-bridged piperidinylidene derivatives as delta opioid modulators
11/26/2009US20090291978 Enzyme Inhibitors
11/26/2009US20090291977 Chromane Derivatives Useful As Acid Pump Antagonists
11/26/2009US20090291976 Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
11/26/2009US20090291975 Dual opioid pain therapy
11/26/2009US20090291974 Bosentan salts
11/26/2009US20090291973 Novel Quinazoline Derivatives and Their Medical Use
11/26/2009US20090291972 Compositions and Methods Relating to Nuclear Hormone and Steroid Hormone Receptors Including Inhibitors of Estrogen Receptor Alpha-mediated Gene Expression and Inhibition of Breast Cancer
11/26/2009US20090291971 Heteroaryl ethers and processes for their preparation
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009US20090291969 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009US20090291968 Substituted indazole derivatives, their manufacture and use as pharmaceutical agents
11/26/2009US20090291967 Small molecule modulators of cell adhesion
11/26/2009US20090291966 Method Of Treating Anxious Major Depressive Disorder
11/26/2009US20090291965 Histone Deacetylase Inhibitors With Aryl-Pyrazolyl-Motifs
11/26/2009US20090291964 Potentiators of Antibacterial Activity
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291962 2-phenyl-6-aminocarbonyl-pyrimidine derivatives and their use as p2y12 receptor
11/26/2009US20090291961 Combination of an mek inhibitor and the src kinase inhibitor azd0530 for use in the treatment of cancer
11/26/2009US20090291960 Pyrrolinidium derivatives as m3 muscarinic receptors
11/26/2009US20090291959 Caspase inhibitors based of pyridazinone scaffold
11/26/2009US20090291958 Substituted PDE5 inhibitors
11/26/2009US20090291957 Heterocyclic derivatives and their use as therapeutic agents
11/26/2009US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
11/26/2009US20090291955 Azacyclohexane Derivatives as Inhibitors of Stearoyl-Coenzyme a Delta-9 Desaturase
11/26/2009US20090291954 Medical Use of Triazine Derivatives
11/26/2009US20090291953 Pharmaceutical salts of reboxetine
11/26/2009US20090291952 Modulators of pharmacokinetic properties of therapeutics
11/26/2009US20090291951 Novel Cyclic Compound Having Pyrimidinylalkylthio Group
11/26/2009US20090291950 Bicyclic heteroaryl inhibitors of pde4
11/26/2009US20090291949 Substitute isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
11/26/2009US20090291948 Sulfonamide peri-substituted bicyclics for occlusive artery disease
11/26/2009US20090291947 Proline analogs as ligands for cannabinoid receptors
11/26/2009US20090291946 Lactam compounds and their use as pharmaceuticals
11/26/2009US20090291945 Cysteine protease inhibitors
11/26/2009US20090291944 Antimicrobial compositions and methods of use
11/26/2009US20090291943 Process for preparing diaminophenothiazinium compounds
11/26/2009US20090291942 Imidazo pyridine derivatives
11/26/2009US20090291941 Tyrosine Kinase Inhibitors
11/26/2009US20090291940 Aminopyrrolidine compound
11/26/2009US20090291939 Treating Alcohol And Or Substance Abuse By Antagonizing Alpha 2 Adrenergic Receptors With Weak Dopamine Blocking
11/26/2009US20090291938 Polo-like kinase inhibitors
11/26/2009US20090291937 Kinase inhibitors
11/26/2009US20090291936 Oxime derivative and preparations thereof
11/26/2009US20090291935 X-nitro compounds, pharmaceutical compositions thereof and uses thereof
11/26/2009US20090291934 Method for decomposing an allergen
11/26/2009US20090291933 Solid state forms of a pharmaceutical
1 ... 2484 2485 2486 2487 2488 2489 2490 2491 2492 2493 2494 2495 2496 2497 2498 2499 2500 2501 2502 2503 2504 ... 7860